Cancer Institute A national cancer institute
designated cancer center

Cutaneous Lymphoma Expertise

The team at the Stanford Multidisciplinary Cutaneous Lymphoma Clinic has achieved world-wide recognition for its success in managing patients with cutaneous lymphomas.  Their experience includes the use of state-of-the-art treatments, including:

  • Topical (nitrogen mustard) and systemic chemotherapy
  • Biological therapies, such as interferon and Targretin
  • Light therapy, such as PUVA and UVB
  • Radiation therapy, including total skin electron beam therapy

See Also

Visit the Stanford Skin Cancer Program for information on Pigmented Lesion and Melanoma; Basal Cell, Squamous Cell, Merkel Cell Carcinoma; and High Risk/Transplant.

See also the Blood and Marrow Transplant Program.

Learn more about cutaneous lymphoma treatments »

Clinical Research Protocols Available to Stanford Patients
The Stanford Lymphoma Program has a wide variety of clinical research protocols available for patient management, including a variety of biological therapies such as immune stimulants, monocloncal antibodies, and vaccines. An integral part of our research is to track the long-term outcome of our patients.

Learn more about current clinical trials »

Patient Story

Patient Paul Raffer, MD, tells his story of being diagnosed with lymphoma after developing a skin rash. Read full story »

Stanford Medicine Resources:

Footer Links: